Thank you for your submission to EMBO reports. We have now received reports from the three referees that were asked to evaluate your study, which can be found at the end of this email. As you will see, all the referees find the topic of interest and in principle suitable for us, and referee 1 only asks that certain issues be clarified. However, referees 2 and 3 consider the study preliminary for publication here at this stage and request a number of additional experiments and controls to make the work more conclusive.
Although EMBO reports publishes short, single-message studies, we require that the data be conclusive and independent lines of evidence used to confirm claims whenever possible. In this respect, I feel it would be important to experimentally address point 1 of referee 2 regarding the use of at least one additional cargo, and perform the controls requested by referee 3 (lack of ubiquitylated endogenous MVB cargoes, controls to Figure 1a , analysis of GFP-Ub incorporation to MVB cargoes, fractionation to support the distribution data in figure 2 and showing that GFP-tagged ESCRTs are functional). Referee 1's point regarding the class E compartment and referee 2's points 2, 3 and 4 could be discussed in the text. Finally, I appreciate that referee 3's very last statement is incorrect and leave up to you the incorporation of the requested reference. If these referee concerns are adequately addressed, we would be happy to accept your manuscript for publication. However, please note that it is EMBO reports policy to undergo one round of revision only and thus, acceptance of your study will depend on the outcome of the next, final version of the manuscript.
I look forward to seeing a revised form of your manuscript when it is ready.
Yours sincerely, Editor EMBO Reports REFEREE REPORTS:
This is a very concise demonstration that ubiquitinated cargo is necessary for ESCRT-mediated formation of intralumenal vesicles. The study makes elegant use of the Hse1-UL36 fusion developed in the Piper lab and EM studies in the atg8Δpep4Δ cells as an assay for ILV production. The conclusion that ubiquitinated cargo is necessary for ESCRT activity is consistent with conventional wisdom but has never been directly demonstrated. The study is quite persuasive and will be an important touchstone for thinking about ESCRT mechanism. I recommend it for publication without any further experimentation, but I would like to see some clarifications and additional quantification of the existing data.
One of the most interesting observations, which is not commented upon, is the lack of class E compartment formation in the Hse1-UL36 strain, which seems to shut down ESCRT function. Normally a shutdown in ESCRT function is yeast induces class E compartments. The authors should state how many sections representing how many cells were inspected by EM, and state the number of class E compartments (if any) observed. If my impression is correct that class E compartment formation is suppressed in this strain, the authors should discuss the possible reasons. If on the other hand class E compartments are formed (just not shown in the sections chosen for display), then the Hse1-UL36 might indirectly block ILV production and the conclusions would need to be hedged much more cautiously. Fig. 2 shows ESCRT-I and ESCRT-II have a strong punctate localization with some diffuse cytosolic background. Typically in yeast ESCRT-I and II are mostly diffuse and it is hard to see the punctate structures without using a vps4Δ strain or deconvolution microscopy. More details on the imaging need to be provided to explain how such clear punctate localization was seen in this study.
Top of pg. 3, the statement that "few, if any Ub-independent cargoes are sorted into intralumenal vesicles" overreaches. There is nothing here to rule out "piggybacking" of non-ubiquitinated cargoes into ILVs instigated by the presence of ubiquitinated cargo.
Minor
Use either Hse1-UL36 or Hse1-DUb consistently.
Referee #2:
MacDonald et al. have discovered that vesicles are absent from the vacuoles of yeast upon expression of a chimeric protein in which the catalytic domain of a deubiquitinating enzyme (DUb) has been fused to Hse1, a non-essential subunit of ESCRT-0. Expression of the Hse1-DUb fusion also prevents localization of ESCRTs I and II to puncta that presumably correspond to endosomes. However, the vacuolar vesicles and ESCRT-I/II localization to puncta is rescued upon coexpression of Mup1 fused in-frame to ubiquitin (Ub). Mup1 is a polytopic membrane protein ubiquitinated on its cytosolic domain, which triggers its endocytosis and subsequent sorting into ILVs at endosomes. The authors conclude that ubiquitinated cargo proteins have an essential role in the function ESCRTs have in ILV budding. The results are inconclusive for the following reasons:
1. Mup1 was the only cargo evaluated, undercutting the implied generalization that ubiquitinated cargoes are essential for ESCRT function. Is the same effect seen with the Ub-GFP-Cps1 fusion used previously by the Emr lab (Katzmann 2001)?
2. Mup1 was found by the Emr lab to bind Art1, which is an adaptor for Rsp5 (Lin 2008). It's possible that the Mup1-Ub fusion rescues ILV budding/ESCRT localization through Rsp5 interactions that otherwise are interfered with in response to the Hse1-DUb fusion. For example, Rsp5 itself is ubiquitinated (Hitchcock 2003) , and Rsp5 binds ubiquitin (French 2009). Therefore, among the choices of cargoes to examine, Mup1 seems particularly fraught with caveats.
3. How effective is the Hse1-DUb fusion in blocking ESCRT localization? Deletion of the VPS4 gene traps ESCRTs I and II at class E compartments (Katzmann 2001; Babst 2002) . If Hse1-Dub really blocks endosomal recruitment of ESCRTs I and II, one would expect them not to be localized at class E compartments in vps4-deleted cells.
4. The authors' EM does not definitively state whether ILV budding is impaired. An alternative possibility is that the Hse1-DUb fusion deubiquitinates a factor required for delivery of endosomal content to vacuoles. For example, Vps18 is a subunit of two endosomal tethering complexes required for different membrane fusion steps in vacuolar transport (Peplowska 2007); Vps18 has a RING-H2 domain (Horazdovsky 1996) , raising the possibility that its function involves ubiquitin interactions disabled by the Hse1-DUb fusion. The Mup1-Ub fusion might, though its Rsp5 connection (see point 2, above), rescue a ubiquitination event critical to Vps18 activity (or critical to the activity of some other Ub-dependent process that affects vacuolar delivery). 3-Is it of general interest to the molecular biolf gy community, Yes The finding is of general interest to the molecular biology community because it shows, by electron microscopy with appropriate mutants and a powerful tool (expression of chimeric ESCRT-DUB), vacuoles with either many or no ILVs.
4-Is the single major finding robustly documented using independent lines of experimental evidence: No The single major finding would be more convincing if better documented by additional data, including biochemical data in particular.
In a previous study, Piper and coworkers showed that the production of a chimeric form of the ESCRT 0 protein Hse1 fused to the catalytic domain of various deubiquitylating enzymes, including UL36, led to defects in the trafficking of various MVB cargos. They demonstrated that these MVB sorting defects could be corrected by producing forms of these cargoes C-terminally fused to uncleavable ubiquitin (such as a GFP-tagged variant of the methionine transporter Mup1-GFP-Ub). In this manuscript, they go one step further in the analysis of the origin of the trafficking defect. Using the pep4 atg8 double mutant, which is known to accumulate in the vacuole, non degraded internal vesicles (ILVs) originating solely from multivesicular bodies (MVBs), they show that Hse1-UL36 production completely prevents ILVs formation, and that this striking morphological defect can be overcome by producing Mup1-GFP-Ub. These observations suggest that Ub-cargoes play a critical role in ILV formation.
The authors also take this analysis further, by suggesting that the production of Hse1-DUB leads to the delocalization of UBD-containing ESCRT proteins, a defect that can be overcome by producing a Ub-cargo chimera that cannot be deubiquitylated.
The key message of this manuscript is interesting and probably correct. However, the authors make a number of assumptions based on inadequately documented data and several controls are missing. Furthermore, there is a lack of references to prior studies consistent with these findings. In more detail: Fig. 1 : -Overall, this study is based on the extensive use of various GFP-tagged versions of the methionine transporter Mup1, and the work previously published by Stringer and Piper (J Cell Biol, 2011) . In this previous study, it was clearly demonstrated that, when Hse1-UL36 is produced in wild-type cells, either as the sole copy of Hse1 or in addition to endogenous Hse1, "it blocks the sorting of a variety of cargoes that would normally undergo Ub-dependent sorting into MVB ILVs". However, no real convincing demonstration was provided that it "effectively removes Ub from cargo early in the MVB sorting process". It was shown that the fusion of active UL36 to the receptor, Ste3, led to the disappearance of bands with a molecular weight greater than that of non ubiquitylated Ste3 (only direct western blots) in end3Δ cells, and that the fusion of active UL36 to Hse1-HA decreased the ubiquitylation status of Hse1 itself (demonstrated by anti-HA immunoprecipitation followed by an anti-Myc-Ub western blot). I think that it is essential to include in this manuscript (at least in the supplementary data) a convincing demonstration that the production of Hse1-UL36 leads to the complete disappearance of ubiquitylated endogenous MVB cargoes. This could be done by assessing the status of cargoes for which antibodies are available (Cps1 and Gap1, for example), under conditions in which cargoes are known to accumulate in a ubiquitylated form, e.g. in vps class E mutants, in doaΔ pep4Δ cells, or, in the case of Gap1, in conditions in which cell surface ubiquitylation is triggered by adding ammonium to the medium and following the disappearance of ubiquitylated bands in a kinetic analysis. The experimental conditions used for the observation of Mup1-GFP in the vacuole are not specified. It is indicated that the cells are grown "in 100 µM CuCl2", but nothing is said about the presence of methionine. We would expect Mup1-GFP to be located at the plasma membane, to undergo endocytosis and sorting to MVBs and then to vacuoles in the presence of methionine. Were the cells treated with methionine here? -Two controls are of particularly importance (and should be supplied, at least in supplementary data) for this figure: the production of Mup1-GFP-Ub alone, and the production of catalytically inactive Hse1-UL36.
- Fig. 1c and d: in the presence of Mup1-GFP plus Hse1-UL36, cells display several abnormalities in addition to the lack of ILVs. Do the structures accumulated in the cells (visible both by DIC and EM) correspond to lipid droplets? This should be specified. The situation appears to be different for the vma4Δ pep4Δ mutant (Fig S1d) . Is this difference significant? If so, why?
Fig. S1a: I am also concerned about the use of references to prior work to support the experiments described in this manuscript. It is stated here that GFP-Ub "can be used to monitor delivery of a variety of Ubcargo into the MVB lumen". This marker appears potentially interesting and its use in different mutants suggests that it could be incorporated into MVB cargoes. However, this has not been formally demonstrated biochemically in the prior manuscript of Ren et al, (J Biol Chem, 2008) . The difference in the distribution of GFP-Ub between cells with and without Hse1-UL36 appears to be very striking (but only one cell presented in each case,as in other figures). However, I think it would be worthwhile providing data complementary to those in Fig. S1a , by carrying out western blotting for GFP (and for Cps1, for example) to investigate the extent to which GFP-Ub is really incorporated into MVB cargoes. The production of Vps27-GFP, in the presence or absence of Hse1-UL36, seems to lead to a class E phenotype. Would the authors like to comment on this?
Finally, I think that the notion that cargoes play a critical role in ILVs formation has already been supported by both in vivo and in vitro experiments that should be cited: EGF stimulation has been shown to stimulate inward vesiculation within EGFR-containing MVBs (White et al., EMBO J 2006 25 1-12) . As EGFR is known to be ubiquitylated, this process probably results from the ubiquitylation of EGFR. Furthermore, the in vitro reconstitution of ILVs formation from giant liposomes is critically dependent on ubiquitylated cargo (Wollert and Hurley, Nature 2010 64 864-869).
1st Revision -authors' response 27 December 2011
We are happy that you and the reviewers were enthusiastic about our manuscript demonstrating a requirement for ubiquitinated cargo in the ESCRT-dependent formation of endosomal intralumenal vesicles (ILV). We would like to thank you and the reviewers for the helpful comments and suggestions on how to strengthen the manuscript. Below we provide a point-by-point comment about each issue and the steps we took to clarify the issues with either more experimentation or altering the text and organization of the manuscript. There were 3 main points overall:
1. We were asked to show that a different type of ubiquitin-conjugated cargo could restore ILV formation. Our original manuscript showed that while an Hse1-DUb chimeric protein blocked delivery of ubiquitinated membrane proteins to ILVs and blocked ILV formation, ILV formation and protein sorting could be restored by expressing an amino acid transporter that was translationally fused to ubiquitin so that it would mimic a real ubiquitinated cargo but be resistant to the activity of the Hse1-DUb. Expressing Mup1-GFP-Ub in Hse1-DUb expressing cells restored ILV formation. Previous studies at the light level also showed that Ste3-GFP-Ub (but not Ste3-GFP) is sorted into the MVB pathway in Hse1-DUb cells (PMID: 21242292 ). In the revised manuscript we now use electron microscopy to show that expressing Ub-GFP-Cps1 and Ste3-GFP-Ub also restores ILV formation. Thus, 3 different biquitincargoes are sufficient to restore ILV formation and diminish the likelihood of different cargo-specific models to which one of the reviewers alludes.
2.
We were asked to demonstrate that the GFP-tagged versions of ESCRT proteins, used to monitor their ability to association with endosomes, function. We now show that all of these ESCRT-fusion proteins complement, functioning in both MVB sorting and sorting of CPY (Vacuolar Protein Sorting).
3. We showed that the association of ESCRTs to the membrane was inhibited by the absence of ubiquitinated cargo. We showed this by GFP fluorescence. It was stated that it is preferable to have multiple lines of evidence to demonstrate this point, and fractionation experiments were suggested. The problem, however, is that many previous studies have shown that the transient association of ESCRTs with membranes does not hold up upon fractionation. ESCRTs can be "trapped" on membranes by deleting factors that disassemble them (e.g. vps4Δ), however, that creates an artificial situation that may be difficult to strictly interpret. Therefore, we have not performed fractionation experiments in Hse1-DUb expressing cells and point out that even by fluorescence, only a portion of the total pool of ESCRTs is concentrated on endosomes in the first place. However, we emphasize that the concept that ubiquitinated cargo promotes endosome association of ESCRTs is supported by our analysis of 4 GFP-tagged and functional ESCRT subunits that represent 2 different ESCRT complexes that function "downstream" of the Hse1/Vps27 ESCRT-0 complex and can be taken as multiple lines of evidence to support our model.
We have also now included additional experimentation to address other concerns of the reviewers. We believe these changes address all of the substantial concerns and suggestions by the reviewers and look forward to hearing from you soon.
Specific Comments
Referee #1: We have substantially expanded the study to investigate localization of both Ub-cargo ( Figure 1 ) and ESCRT subunits ( Figure 4 ) in a Class E mutant (vps4Δ), and then monitor the effect of expressing the Hse1-Dub in these strains. Expressing Hse1-DUb protein does not induce a class E phenotype nor does it suppress the phenotype caused by deletion of ESCRT-I, II, or Vps4. Deletion of ESCRTs causes multiple defects including the accumulation of enlarged aberrant endosomes (class E compartments) and a block in endosome-TGN recycling of the CPY-receptor resulting in CPY secretion. Expressing Hse1-DUb does not cause CPY secretion nor does it affect the formation of class-E compartments (PMID: 21242292 ). In addition, the ESCRT apparatus is fully capable of making ILVs and executing MVB formation once suitable cargo is present. Thus, even for MVB sorting, the ESCRTs are functional. Indeed, it is interesting that using Hse1-DUb is perhaps the first clear case where one can separate ILV formation from the other ESCRTdependent functions since a class E pheonotype is not observed.
One of the most interesting observations, which is not commented upon, is the lack of class E compartment formation in the
The reviewer brings up another point, which is that Hse1-DUb may suppress the class E phenotype. This was important to determine. However, we do not see that. Expressing Hse1-DUb in vps4Δ mutants does not prevent accumulation of large FM4-64-labelling class E compartments and does not suppress the CPY secretion phenotype (new data: Fig. 1c and 5a & b) . The possibility that Hse1-DUb could suppress the class E phenotype would support many interesting models, such as the idea that endosomes must rid themselves of ubiquitinated cargo in order to properly mature. However, that does not seem to be what is happening since Hse1-DUb expression is effective at removing ubiquitin from cargo and bulk ubiquitin that accumulates on the class E compartment (new data: Fig 1c) and yet does not suppress the class E phenotype. The basis for the morphometry presented in Figure 4 are now stated.
Fig. 2 shows ESCRT-I and ESCRT-II have a strong punctate localization with some diffuse cytosolic background. Typically in yeast ESCRT-I and II are mostly diffuse and it is
hard to see the punctate structures without using a vps4Δ; strain or deconvolution microscopy. More details on the imaging need to be provided to explain how such clear punctate localization was seen in this study.
We now provide additional details in the Materials and Methods section on how the cells were grown and photographed. There are 3 salient points about this experiment: First, each ESCRT subunit was tagged at its endogenous locus with a C-terminal GFP tag, ensuring an appropriately low and consistent level throughout the population of cells. We wanted to be careful to only state that the data suggest that "few if any Ubindependent cargos are sorted". We think this is a fair point to bring up in the discussion as the data do indeed suggest that to us. We meant not to imply exhaustive proof was provided and have altered the discussion to make this clearer. We point out that if a nonubiquitinated protein associates with a ubiquitinated protein in order to undergo MVB sorting (a piggy-back fashion), it would still qualify as a ubiquitin-dependent process.
Minor: Use either Hse1-UL36 or Hse1-DUb consistently.
We now use Hse1-DUb throughout.
Mup1 was the only cargo evaluated, undercutting the implied generalization that ubiquitinated cargoes are essential for ESCRT function. Is the same effect seen with the Ub-GFP-Cps1 fusion used previously by the Emr lab (Katzmann 2001)?
We now use electron microscopy to show that expressing Ub-GFP-Cps1 or Ste3-GFP-Ub restores ILV accumulation in Hse1-DUb expressing cells. How a ubiquitin-binding domain with Rsp5 contributes to ILV formation may be interesting but is not that relevant to the specific points we want to make. We now show that cargo other than Mup1-GFP-Ub can restore ILV formation, so we hope that will satisfy the reviewer and circumvent any potential problems associated with the biology of Mup1. With reference to Rsp5 in particular, the reviewer is evoking a particular model for how ubiquitinated Mup1 could engage the ESCRT machinery-via the ubiquitin-binding domain of Rsp5. In theory, this could even operate a variety of endogenous cargo as well. The central thesis of our study does not hinge on exactly how ubiquitinated cargo engages the ESCRT apparatus, merely that Ub-cargo promotes ILV formation and ESCRT:endosome association. Thus, the particular way ubiquitinated cargo engages the ESCRT apparatus (via ubiquitin binding domains of ESCRT-I or ESCRT-II or indirectly via Rsp5) is not relevant to the model we present.
Mup1 was found by the Emr lab to bind
Second, the idea that mere physical association with Rsp5 is sufficient to drive MVB sorting is a proposed model built from previous observations about the behavior of the Rsp5-associating Sna3 protein (PMID: 17603537). This model is not carved in stone and the caveats suggested are not obvious and quite speculative. We point out that Mup1-GFP-Ub undergoes MVB sorting in the complete absence of Rsp5 (PMID: 21242292). Loss of Vps4 locks several ESCRTs as well as a variety of other protein complexes on endosomes, thus creating an "artificial" condition that strongly promotes localization of ESCRTs to endosomes. Thus, we did not share the prediction of the reviewer that compromise of ESCRT recruitment by loss of cargo would necessarily be observed in vps4Δ cells for the model to be correct. We did do the experiment and included it in Figure  4 . It shows that loss of Vps4 creates an FM4-64 staining class E endosome to which ESCRTs accumulate even with Hse1-Dub expressed. In the discussion we interpret this to mean that in the absence of cargo ESCRTs can still cycle onto endosomes at some rate but fail to be significantly retained there. This is how vps4Δ cells could essentially lock ESCRT subunits on to endosomes when they initially associate, where they subsequently accumulate. Other interpretations are certainly possible which is why this point is relegated to the Discussion. 
How effective is the Hse1-DUb fusion in blocking ESCRT

The authors' EM does not definitively
dependent process that affects vacuolar delivery).
It is possible that Hse1-DUb deubiquitinates proteins we do not know about, but a central point of the paper is that the effects of Hse-DUb on ILV formation are completely reversed simply by expressing a ubiquitinated cargo resistant to the DUb. This shows that the defect is caused by the loss of ubiquitinated cargo rather than the deubiquitination of some yetunidentified protein since that unidentified protein would still be susceptible to deubiquitination. Other aspects of the endocytic pathway such as fusion to the vacuole function normally since Hse1-DUb does not induce CPY secretion or disrupt vacuole morphology or endocytic transport of FM4-64 dye to the vacuole (phenotypes observed when Vps18-associated tethering factors lose activity). The idea that Hse1-DUb blocks ILV formation by eliminating Ub-cargo is the simplest and fairest interpretation of the data. This in turn correlates well with the later part of the paper that shows ESCRTs are recruited in response to Ub-cargo. We have clarified the text in order to emphasize the experimental findings and to discuss what these mean. We feel our model is the most likely explanation for the data presented, and have deliberately avoided discussion of alternatives that rely too heavily on speculation.
Referee #3:
In this previous study, it was clearly demonstrated that, when Hse1-UL36 is produced in wild-type cells, either as the sole copy of Hse1 or in addition to endogenous Hse1, "it blocks the sorting of a variety of cargoes that would normally undergo Ub-dependent sorting into MVB ILVs". However, no real convincing demonstration was provided that it "effectively removes Ub from cargo early in the MVB sorting process.
The idea that Hse1-DUb removes Ub early in the sorting process was meant to be in contrast to it removing ubiquitin late in the sorting process. Doa4 removes Ub late in the sorting process when cargo is safely incorporated into the forming vesicle. The activity of Doa4 does not block MVB sorting. Thus the activity of Hse1-DUb, which does block sorting, must act earlier. We wanted to make the point that Hse1-DUb does a very good job in deubiquitinating Ub-cargo and blocking its MVB sorting. This is supported by previous experiments (PMID: 21242292), where we documented the fate of a whole host of particular MVB cargoes. In the present manuscript, we show this in an additional way using GFP-Ub, which accumulates in vacuoles as a consequence of being conjugated to MVB cargo. Reviewer 3 has suggested including more experiments to support the point that Hse1-DUb deubiquitinates MVB cargo. In particular they propose monitoring the extent of ubiquitination of particular proteins that undergo Ub-dependent MVB sorting. This is a good suggestion for strengthening the manuscript, however, there are several problems with this particular suggested experiment.
It was shown that the fusion of active UL36 to the receptor, Ste3, led to the disappearance of bands with a molecular weight greater than that of non ubiquitylated Ste3 (only direct western blots) in end3Δ; cells, and that the fusion of active UL36 to Hse1-HA decreased the ubiquitylation status of Hse1 itself (demonstrated by anti-HA immunoprecipitation followed by an anti-Myc-Ub western blot). I think that it is essential to include in this manuscript
In the current experimental paradigm, we are tethering a DUb to the ESCRT complex. The intent is that Hse1-DUb has an effect only on a subpopulation of that cargo engages the ESCRT machinery at the endosome. (Indeed, previous studies showed that merely expressing a DUb in the cytosol has no effect on the MVB sorting of a number of cargos). It is known that cell surface proteins such as Ste3 and Ste2 are ubiquitinated at the cell surface and likely other compartments. Cps1 is probably ubiquitinated in the Golgi since it accumulates in a ubiquitinated state in pep12Δ mutants. We would not expect Hse1-DUb to quantitatively remove ubiquitin from the entire pool of a particular protein that undergoes MVB sorting. Nor can one make an adequate prediction for what percentage of a pool "should" be removed. The suggestion for a kinetic analysis is appreciated. However, it is unclear what proportion of Ub-Gap1 should be diminished to either support or negate the idea that Hse1-DUb is working effectively. On a technical level, we also point out that even in the best circumstances only a minor portion of Gap1 is ubiquitinated. The same is true for Mup1. Furthermore, these experiments are extremely challenging given the polytopic nature of these transporters -we have spent significant time optimizing immunoblot conditions for analyzing Mup1, and our best efforts still detect the majority of protein as insoluble aggregates that cannot be resolved by SDS-PAGE. A 30-40% diminishment of the extent of ubiquitinated transporter at some key time point would be one expectation. But if it was observed that it was 20% or 50% instead, it would just as well support the idea that Hse1-DUb deubiquitinates cargo on endosomes.
Instead, we performed a different experiment to address the reviewer's concerns. Our previous studies showed that GFP-Ub accumulates on class E compartment endosomes (PMID: 18508771). This is consistent with the accumulation of ubiquitinated proteins on mammalian endosomes when ESCRT function is blocked. We found that vps4Δ cells expressing Hse1-Dub still form a Class E compartment, however the accumulation of GFPUb on enlarged endosomes in these cells is dramatically diminished. In addition, we find that Mup1-GFP not only fails to enter the lumen of the vacuole, but that some actually recycles back to the PM in DUb expressing cells. This observation, combined with the other experiments, substantiates the view that Hse1-DUb is active towards Ub-cargo at the endosome. In addition, they serve as important control to show that the accumulation of ESCRT-GFP subunits in vps4Δ Hse1-DUb expressing cells is simply not due to the inability of Hse1-DUb to deubiquitinate proteins in class E compartment endosomes (relevant to point 3 from Reviewer 2).
3. Fig. 1a The cells were treated with methionine. This has now been clarified in the text.
Two controls are of particularly importance (and should be supplied, at least in supplementary data) for this figure: the production of Mup1-GFP-Ub alone, and the production of catalytically inactive Hse1-UL36.
These two experimental conditions are now provided. They show that Mup1-GFP-Ub alone is sorted along the MVB pathway into ILV that accumulate within the vacuole. Expressing catalytically inactive Hse1-DUb has no effect of MVB sorting of GFP-tagged cargo or accumulation of ILVs.
Fig. 1c and d: in the presence of Mup1-GFP plus Hse1-UL36, cells display several abnormalities in addition to the lack of ILVs. Do the structures accumulated in the cells (visible both by DIC and EM) correspond to lipid droplets? This should be specified. The situation appears to be different for the vma4&#x0394; pep4&#x0394; mutant (Fig S1d). Is this difference significant? If so, why?
Lipid droplets are evident by EM for all cell types and we did not notice any differences regarding this. We will point out that the EM was done in multiple ways to reveal the intravacuolar vesicles and that the methods are very different. This was done to provide the multiple lines of evidence for our conclusions. We also do not see any abnormality by fluorescence or DIC of the cells when examining the population as a whole. These points are now explained better in the text.
I am also concerned about the use of references to prior work to support the experiments described in this manuscript. It is stated here that GFP-Ub "can be used to monitor delivery of a variety of Ub-cargo into the MVB lumen". This marker appears potentially interesting and its use in different mutants suggests that it could be incorporated into MVB cargoes. However, this has not been formally demonstrated biochemically in the prior manuscript of Ren et al, (J Biol Chem, 2008). The difference in the distribution of GFP-Ub between cells with and without Hse1-UL36 appears to be very striking (but only one cell presented in each case,as in other figures). However, I think it would be worthwhile providing data complementary to those in Fig. S1a, by carrying out western blotting for GFP (and for Cps1, for example) to investigate the extent to which GFP-Ub is really incorporated into MVB cargoes.
The experiments we discuss in point 2 above address this concern. We show that GFP-Ub is readily incorporated into the pool of ubiquitin-conjugated proteins and that it is removed from vps4Δ endosomes by Hse1-DUb (Fig. 1b and c) . Previous published studies (PMID: 18508771) further support this marker as a proxy for ubiquitinated MVB cargo since it accumulates in the vacuole in an ESCRT dependent fashion and hyperaccumulates there in cells lacking the Doa4 ubiquitin-peptidase that works at the end of the MVB sorting process. We also show new data demonstrating that a significant amount of GFP-Ub accumulates in the vacuole as a vacuolar processed GFP fragment ( Supplemental Fig.  S1 ); this complements the fluorescence data (Fig. 1) .
In support of the data presented, a fractionation (gradients, or at least soluble/membrane-bound fractions) of the various Vps-GFP proteins would be more convincing. Are the GFP-tagged versions of the ESCRT I and II proteins examined functional?
The GFP tagged versions of ESCRT-0, -I and -II are functional. We now provide CPY secretion data showing that these GFP-tagged protein support proper sorting of CPY unlike vps4 or other ESCRT null mutants. In addition, proper sorting of Mup1-RFP-Ub into the vacuole can be is shown in the cells in Figure 4 . We have included further demonstration that all these GFPtagged ESCRTs can facilitate proper sorting of a well-defined MVB cargo, Sna3 ( Figure 5 ).
Unfortunately, fractionation experiments to demonstrate the low level of endosomal association of ESCRTs in wild-type cells is not technically feasible. Many previous experiments have shown that under these conditions, ESCRTs essentially fractionate as soluble proteins. Despite this, we use 4 different GFP-ESCRT subunits from 2 different ESCRT complexes in support of this point.
The production of Vps27-GFP, in the presence or absence of Hse1-UL36, seems to lead to a class E phenotype. Would the authors like to comment on this?
We see that Vps27-GFP is localized to endosomes and find that it does not induce a class E phenotype. Also, we find that Vps27-GFP complements for MVB sorting and CPY sorting (Figure 5a & b) . If anything, Vps27-GFP in Hse1-DUb expressing cells seems to localize to more yet smaller endosomes -the opposite of a class E phenotype. We now comment on the data.
Finally, I think that the notion that cargoes play a critical role in ILVs formation has already been supported by both in vivo and in vitro experiments that should be cited: EGF stimulation has been shown to stimulate inward vesiculation within EGFR-containing MVBs (White et al., EMBO J 2006 25 1-12). As EGFR is known to be ubiquitylated, this process probably results from the ubiquitylation of EGFR. Furthermore, the in vitro reconstitution of ILVs formation from giant liposomes is critically dependent on ubiquitylated cargo (Wollert and Hurley, Nature 2010 64 864-869).
In some ways those studies are consistent. Yet, the study from White et al implied that EGF accomplishes increased ILV formation by a signaling mechanism involving annexin 1. The studies or Wollert et al. use an in vitro system, one with which ILV can be made to form with only ESCRT-III under some conditions. It is hard to extrapolate what happens in vivo in regards to how Ub-cargo effects ILV formation from those types of experiments.
2nd Editorial Decision 18 January 2012
Thank you for your patience while your revised study has been under peer-review. We sent it to referees 1 and 3, who have now returned their assessments. Referee 1 supports publication and has no further comments, whereas referee 3 is supportive of the study but has several outstanding concerns (please see below). I have sought additional advice from our editorial board in this case and -although acknowledging that some of the requested experiments are justified (in particular the use of SDS gels and showing that endogenous cargo is deubiquitinated by Hse1-UL36)-s/he considers that the ILV formation phenotype is sufficiently strong to support the conclusions made and publication should not be delayed any further.
Therefore, I am very pleased to accept your study for publication in the next available issue of EMBO reports. Thank you for your contribution to our journal! Browsing through the manuscript prior to acceptance, I have realized that -although large numbers of cells were analyzed for Ub-GFP in the class E compartment in Figure 1d , the graph does not include error bars, which I think would strengthen it. Could I ask you to please include them?
Thank you again for your contribution to EMBO reports and congratulations on a successful publication. Please consider us again in the future for your most exciting work.
Yours sincerely, Editor EMBO Reports REFEREE REPORT:
Referee 3 report
My general remarks (1-4) remain the same as in my prior report.
The revised manuscript by MacDonald et al. has been strengthened by the inclusion of new data. In particular, it is now shown that Hse1-DUB expression does not lead to the class E phenotype. It is also shown that GFP-Ub is, to some extent, incorporated into proteins (new Fig. 1b) , providing some support for the interpretations of fluorescent experiments making use of GFP-Ub put forward (ex Fig. S1 , new Fig. 1c ). The authors also state that GFP-Ub expression leads to formation of a vacuolar processed form of GFP (new Fig. S1 ). However, I feel that this observation would be completely informative only if the authors also present the profile of a ubiquitylated cargo in cells with and without GFP-Ub expression. Sna3-HA would be a suitable cargo for study, as Piper et al. have recently shown (MacDonald et al. Traffic 2011) that ubiquitylated forms of Sna3-HA are readily detected on western blots of total protein extracts: is GFP-Ub readily incorporated into this protein?
My prior comment: ("In this previous study, it was clearly demonstrated that, when Hse1-UL36 is produced in wild-type cells, either as the sole copy of Hse1 or in addition to endogenous Hse1, "it blocks the sorting of a variety of cargoes that would normally undergo Ub-dependent sorting into MVB ILVs". However, no real convincing demonstration was provided that it "effectively removes Ub from cargo early in the MVB sorting process") did not relate solely to the point in the pathway at which Hse1-DUB deubiquitylates cargoes. I was also requesting a clear biochemical demonstration of this deubiquitylation.
I am not convinced by the response to this critical point provided by the authors. When the authors state: "We would not expect Hse1-DUb to quantitatively remove ubiquitin from the entire pool of a particular protein that undergoes MVB sorting. Nor can one make an adequate prediction for what percentage of a pool "should" be removed." they could simply test this, with Cps1 or Sna3 for example, both of which give very clear ubiquitylated bands.
The authors state: "The suggestion for a kinetic analysis is appreciated. However, it is unclear what proportion of Ub-Gap1 should be diminished to either support or negate the idea that Hse1-DUb is working effectively. On a technical level, we also point out that even in the best circumstances only a minor portion of Gap1 is ubiquitinated.", I emphasize that this proportion is actually not so minor for Gap1 (see Springael Y and André, B Mol Biol Cell 1998, Springael Y et al., J Cell Sci 1999) , or for instance for another plasma membrane transporter undergoing signal-mediated ubiquitin-mediated endocytosis (see Gitan RS et al, J Biol Chem, 2003) .
I am also afraid that I simply cannot accept the authors' statement that "Furthermore, these experiments are extremely challenging given the polytopic nature of these transporters -we have spent significant time optimizing immunoblot conditions for analyzing Mup1, and our best efforts still detect the majority of protein as insoluble aggregates that cannot be resolved by SDS-PAGE". So many people have studied proteins with multiple transmembrane spans either in yeast (many studies on the plasma membrane ATPase Pma1, endocytosis of multiple transporters),or in mammals over the years, and experimental conditions preventing aggregation have been described. One clear precaution is to avoid heating proteins suspended in sample buffer to temperatures greater than 37 degree Celsius. The long list of possible protocols includes that described by Horak and Wolf (J Bacteriol. 2001 May; 183(10) : 3083-3088). There is therefore absolutely no reason to address this question by an indirect approach, as described by the authors in their response to my initial comment on this point.
However, if the authors prefer, they could analyse the effect of Hse1-DUB expression on the ubiquitylation profile of an MVB cargo with Cps1, rather than Mup1. The ubiquitylation pattern of this protein is so striking, as described years ago by Emr and coworkers (see Katzman, Babst and Emr, Cell 106 145-155 2001) , that a decrease in ubiquitylation, even if only partial, should be readily detectable. Ubiquitylation could be assessed, in the presence and absence of Hse1-DUB expression, for instance, in vps4 cells (see below), in which ubiquitylated forms of Cps1 normally accumulate.
In conclusion, I strongly suggest to include these experiments in order to further improve this manuscript.
Correspondence 31 January 2012
Thank you for accepting our manuscript describing a role for ubiquitinated cargo in the formation of ESCRT-dependent intralumenal vesicles. We are returning a revised version with high resolution figures and the data showing standard deviation error bars associated with our quantification for how well endosome localized Hse1-DUb depletes the accumulation of ubiquitinated proteins at endosomes as requested.
We are happy for the referee comments and our responses to be made public since they may help readers come to their own conclusions about our findings. In light of this and the latest comments from one reviewer, we wanted to emphasize a couple of points.
The point of the last reviewer's suggestion was to provide data indicating that Hse1-DUb deubiquitinates proteins at the endosome. We did perform additional experiments with a particular cargo to show that Hse1-DUb is active against MVB cargo. It is at the end of this letter. But as we explained in our original rebuttal letter and again below, we think there are too many caveats to draw strong conclusions from this type of analyses, even though the finding itself ostensibly supports our model. We provide it for those who are curious, but feel it is unnecessary to include in the completed manuscript. Instead, the manuscript addresses this issue in a different way. We believe following GFP-Ub serves as a good marker for ubiquitinated cargo proteins that enter into the MVB. This is because it accumulates in the vacuole in an ESCRT-dependent fashion. In addition, it accumulates on endosomes of cells lacking ESCRT function, as has been described for a large number of MVB cargoes in both mammalian and yeast cells. Using GFP-Ub as a reporter of a wide range of ubiquitinated proteins coupled with the localization of particular MVB cargo proteins with GFP supports the simple conclusion we make that Hse1-DUb expression does a very good job in blocking the sorting of ubiquitinated proteins into the vacuole lumen. Using GFP-Ub allowed us to demonstrate whether Hse1-DUb can deubiquitinate proteins at the endosome, and the manuscript indeed shows this nicely. We believe these experiments answer the overall conceptual question and the remaining reviewer comments center around whether we should have pursued the particular specific experiments they propose. The idea is to synchronize a population of MVB cargo proteins (such as the Mup1 transporter at the plasma membrane), to undergo internalization, ubiquitination, and MVB sorting and determine whether Hse1-DUb can decrease the extent of ubiquitination as it moves into endosomes. This is a nice idea, but is comes with real caveats and technical challenges that are not appreciated by the reviewer. As proposed this type of experiment suffers from a number of drawbacksespecially ones that limit the ability to reliably measure the small changes in ubiquitination that would be expected.
First, internalization and MVB sorting of Mup1 with methionine addtion is a stochastic process. The rate of Mup1 degradation describes a broad exponential curve, not a step function. At intermediate times, proteins like Mup1 are distributed between multiple compartments (such as the PM, endosomes, and vacuole) and quantifying the levels of Mup1 (and ubiquitinated species) at ESCRT-0 containing endosomal compartments is extremely challenging. Similar difficulties are related to analysis of other MVB cargoes.
Second, is that this experiments asks us to differentiate between two different endosomal cargo deubiquitination events that are predicted to happen pretty much at the same time. In wild-type cells, ubiquitinated cargo is largely deubiquitinated by Doa4 just prior to being enveloped into ILVs. Hse1-DUb should be working earlier than this step, but both deubiquitination steps happen pretty much when cargo is being sorting at the endosomes. The idea that the temporal separation between these two events is long enough to distinguised using biochemical analysis (especially since a highly synchronized wave or protein trafficking is not achieved) is unjustified by any published study.
Third, although expression of Hse1-DUb blocks MVB cargo, we find that a certain population of these proteins are recycled between other endosmal compartments and even the plasma membrane (Gap1 and Mup1), thus allowing those proteins to become ubiquitinated again. These "re-ubiquitinated" species would further compromise the temporal synchrony of a protein population to be followed by this technique.
Fourth, and perhaps most importantly, all of these and other caveats make it impossible to predict how much less a given population of cargo should be ubiquitinated to be in support of the idea that Hse1-DUb deubiquitinates endosomal cargo. This is the heart of the matter. Does a 25% decrease in the ubiquitination of a population of cargo argue for or against a comprehensive activity for Hse1-DUb at endosomes? Does 35%?
Fifth, the reasons we did not pursue other strategies such as following a population of Mup1 or Gap1 were based on technical reasons, not excuses. Immunoprecipitation methods that are excessively gentle with non-denaturing detergents are not appropriate for this approach. Our experience with solubilizing Mup1 (an example of which is shown in the supplementary data in the recent Sna3 paper to which the reviewer refers) shows that this protein is highly susceptible to rapid aggregation-a problem that keeping extracts <37°C simply does not prevent. While there are published studies examining ubiquitination of these transporters, none have actually shown that the methods for immunoisolation of these proteins results in their quantitative recovery. Many of these methods use extended protocols that we find indeed do lose transporters along the way. In addition, the extent of ubiquitinaiton of these transporters not only varies between papers and between groups, but can also vary within the figures of a single paper. What that means is that while these methods can suffice to follow large changes in transporter ubiquitination, they are hardly suited to find the subtle differences (20-50% decreases in ubiquitination) one might hope to achieve in the suggested experiment.
Again, we emphasize that we have provided a number of controls experiments, shown vesicle formation is restored by a pre-ubiquitinated cargo, and shown that Hse1-DUb rids endosomes of accumulated ubiquitinated proteins in vps4 mutants in lieu of the particular experiment requested by the reviewer.
The suggestion of Sna3 by the reviewer is appreciated, and one that we did not initially pursue given the fact that we only just resolved the question of whether Sna3 was a conventional Ub-dependent MVB cargo. Below is an analysis of Sna3 along the lines of what the reviewer suggested. In Hse1-DUb expressing cells, Sna3 is blocked from the vacuole lumen and instead accumulates in endosomal compartments. However, without Hse1-DUb, Sna3 rapidly accumulates in the vacuole lumen, which confounds comparison whether or not the intravacuolar population is stabilized, for example: by deleting the PEP4 gene. The only way to accumulate Sna3 in endosomes for comparison +/-DUb is using a class E/ESCRT null mutant. The figure below shows the distribution of Sna3-GFP in vps4 null cells, wild-type cells, and wild-type cells expressing Hse1-DUb to illustrate this point. We measured the proportion of ubiquitinated Sna3-HA in vps4 cells and in wild-type cells expressing Hse1-DUb-both conditions in which Sna3 is endosomal. We find that the proportion of Ub-Sna3 is decreased in Hse1-DUb expressing cells using western blotting and imaging via infrared fluorescence. This is consistent with all of our other data and provides the type of analysis the reviewer requested. But because of the caveats mentioned above that undermine conclusions drawn from these data, we are comfortable with only including it here in correspondence and not in our revised manuscript.
